The collagen 2.3 and 3.6 promoters have been used to drive Cre expression for generation of conditional transgenic mutant mice. Within the bone, Col3.6 is expressed by mesenchymal precursor cells and their downstream progeny, while Col2.3 is more osteoblast specific. Our generation of transgenic mice with Col2.3-Cre- and Col3.6-Cre-driven deletion of the long-form leptin receptor (ObRb) necessitated a thorough analysis of the nonspecific expression of these promoters in the central nervous system. Both Col2.3 and Col3.6 were capable of forcing loxP recombination in the brain as demonstrated by EGFP expression in ROSA reporter mice. Expression of Col2.3 was limited to the central base of the brain near the third ventricle. In contrast, robust expression of Col3.6 was noted throughout the brain, centering near the distal third ventricle, third ventricle, and aqueduct. We subsequently analyzed the colocalization of leptin-responsive P-Stat3 neurons with Col3.6-expressing neurons. Approximately 5–10% colocalization was noted in leptin-responsive brain areas such as the arcuate nucleus, dorsal medial hypothalamus, ventral premammillary nucleus, and lateral hypothalamus. Injection of 3.6Cre+F/F ObRb knockout mice with leptin confirmed the presence of an intact P-Stat3 response that was dampened in the lateral hypothalamus (p < 0.050). This test was done to explore the contribution of neural leptin signaling to the bone phenotype of the 3.6Cre+F/F mice. Our analysis indicates that neural ObRb deletion, while present, is likely not the sole driver of femoral changes through traditional sympathetic circuits.

Keywords:
Leptin, Bone, Collagen promoter, Brain, Leptin receptor
1.
Abramoff, M.D., P.J. Magelhaes, S.J. Ram (2004) Image Processing with ImageJ. Biophotonics Int 11: 36–42.
2.
Ducy, P., M. Amling, S. Takeda, M. Priemel, A.F. Schilling, F.T. Beil, J. Shen, C. Vinson, J.M. Rueger, G. Karsenty (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100: 197–207.
3.
Ealey, K.N., D. Fonseca, M.C. Archer, W.E. Ward (2006) Bone abnormalities in adolescent leptin-deficient mice. Regul Pep 136: 9–13.
4.
Faouzi, M., R. Leshan, M. Bjornholm, T. Hennessey, J. Jones, H. Munzberg (2007) Differential accessibility of circulating leptin to individual hypothalamic sites. Endocrinology 148: 5414–5423.
5.
Franklin, K.B.J., G. Paxinos (1997) The Mouse Brain in Stereotaxic Coordinates. San Diego, Academic Press.
6.
Hamrick, M.W., C. Pennington, D. Newton, D. Xie, C. Isales (2004) Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34: 376–383.
7.
Heffner, C., Y. Sharma (2010) B6.Cg-Tg(Fabp4-cre)1Rev/J (Stock No 005069). Bar Harbor, Jackson Laboratory.
8.
Iwaniec, U.T., S. Boghossian, P.D. Lapke, R.T. Turner, S.P. Kalra (2007) Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice. Peptides 28: 1012–1019.
9.
Kalajzic, Z., P. Liu, I. Kalajzic, Z. Du, A. Braut, M. Mina, E. Canalis, D.W. Rowe (2002) Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. Bone 31: 654–660.
10.
Krebsbach, P.H., J.R. Harrison, A.C. Lichtler, C.O. Woody, D.W. Rowe, B.E. Kream (1993) Transgenic expression of COL1A1-chloramphenicol acetyltransferase fusion genes in bone: differential utilization of promoter elements in vivo and in cultured cells. Mol Cellular Biol 13: 5168–5174.
11.
Leinninger, G.M., Y.H. Jo, R.L. Leshan, G.W. Louis, H. Yang, J.G. Barrera, H. Wilson, D.M. Opland, M.A. Faouzi, Y. Gong, J.C. Jones, C.J. Rhodes, S. Chua, Jr., S. Diano, T.L. Horvath, R.J. Seeley, J.B. Becker, H. Munzberg, M.G. Myers, Jr. (2009) Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab 10: 89–98.
12.
Liu, F., H.W. Woitge, A. Braut, M.S. Kronenberg, A.C. Lichtler, M. Mina, B.E. Kream (2004) Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int J Dev Biol 48: 645–653.
13.
Mao, X., Y. Fujiwara, A. Chapdelaine, H. Yang, S.H. Orkin (2001) Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood 97: 324–326.
14.
McMinn, J.E., S.M. Liu, I. Dragatsis, P. Dietrich, T. Ludwig, S. Eiden, S.C. Chua, Jr. (2004) An allelic series for the leptin receptor gene generated by CRE and FLP recombinase. Mamm Genome 15: 677–685.
15.
Pelleymounter, M.A., M.J. Cullen, M.B. Baker, R. Hecht, D. Winters, T. Boone, F. Collins (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540–543.
16.
Scheller, E.L., J. Song, M.I. Dishowitz, F.N. Soki, K.D. Hankenson, P.H. Krebsbach (2010) Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells. Stem Cells 28: 1071–1080.
17.
Steppan, C.M., D.T. Crawford, K.L. Chidsey-Frink, H. Ke, A.G. Swick (2000) Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Peptides 92: 73–78.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.